HCAT vs META

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

HCAT

38.7
AI Score
VS
META Wins

META

58.7
AI Score

Investment Advisor Scores

HCAT

39score
Recommendation
SELL

META

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT META Winner
Forward P/E 7.764 18.2482 HCAT
PEG Ratio 0 0.8151 Tie
Revenue Growth -12.7% 28.0% META
Earnings Growth 0.0% -13.4% HCAT
Tradestie Score 38.7/100 58.7/100 META
Profit Margin -90.6% 29.8% META
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD META

Relative Price Performance (Last 90 Days)

HCAT 1M: -23.9% · 3M: +18.6% META 1M: -9.3% · 3M: -9.5%

Current Technical Phase

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 32.4 · Price: $1.53

META

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 39

RSI (14): 38.6 · Price: $549.90

Fundamentals Snapshot

Metric HCAT META
Market Cap
Forward P/E 38.4 16.2
Trailing P/E 20.5
Revenue (TTM)
Revenue Growth -0.1% 0.3%
Gross Margin 0.5% 0.8%
Operating Margin -0.1% 0.3%
EPS -3.54 26.65
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, META is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.